Anebulo Pharmaceuticals Inc (ANEB)
1.84
-0.04
(-2.13%)
USD |
NASDAQ |
Nov 01, 16:00
Anebulo Pharmaceuticals Total Assets (Quarterly): 4.073M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.073M |
| March 31, 2024 | 5.996M |
| December 31, 2023 | 7.501M |
| September 30, 2023 | 9.048M |
| June 30, 2023 | 11.67M |
| March 31, 2023 | 14.43M |
| December 31, 2022 | 16.89M |
| September 30, 2022 | 19.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 15.58M |
| March 31, 2022 | 17.25M |
| December 31, 2021 | 18.96M |
| September 30, 2021 | 20.50M |
| June 30, 2021 | 21.65M |
| March 31, 2021 | 4.292M |
| December 31, 2020 | 2.610M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.610M
Minimum
Dec 2020
21.65M
Maximum
Jun 2021
12.68M
Average
14.43M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Revance Therapeutics Inc | 494.80M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.2606M |
| Shareholders Equity (Quarterly) | 3.812M |